Global Companion Diagnostic Market

Mar 2020| VMR290B| Verified Market Research

Report Highlights

Companion Diagnostics Market

According to Verified Market Research, Global Companion Diagnostics Market was valued at USD 2.98 Billion in 2018 and is projected to reach USD 9.51 Billion by 2026, growing at a CAGR of 15.59 % from 2019 to 2026.

Global Companion Diagnostics Market Outlook

Companion diagnostic will continue to increase in some applications to disease areas. The commercial success of drugs depends on the companion diagnostic. The increasing burden of disease and economic incentives for drug development are the two primary factors driving growth. Companion diagnostics reduces development time and Rx development costs and results in more favorable reimbursement by illustrating comparative effectiveness. In collaboration with pharmaceutical companies, the market is undergoing a remarkable change by developing and identifying the diagnostics to target patients. Approval and commercialization of any drug are challenging, before preferring any medicine or drug to humans it experiments on the animal to analyses its productive or positive as well as negative effects which further helps the researcher whether the drug is suitable for a disorder and human use. However, increasing development costs is restraining the growth of the market.

Global Companion Diagnostics Market Competitive Landscape

The Global Companion Diagnostics Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as F. Hoffmann-La Roche AG, Agilent Technologies, Inc., QIAGEN N.V., Abbott Laboratories, Inc., Almac Group, Danaher Corporation, Illumina Inc., Biomrieux SA, Myriad Genetics, Inc., and Sysmex Corporation.

Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.

Similar Reports from Verified Market Research

Global Companion Diagnostics Market

  • Date - Dec 2018
  • Code - VMR290A

The Global Companion Diagnostics Market was valued at USD 2.03 billion in 2016 and is projected to reach USD 10.30 billion by 2025, growing at a CAGR of 19.78% from 2017 to 2025.

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a ...

Verified Market Research
Price: $2995

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.